港股異動 | 百濟神州(6160.HK)漲6.89% 獲權對BAT1706進行開發及商業化
格隆匯8月26日丨百濟神州(6160.HK)現報150.5港元,漲幅6.89%,最新總市值1761.36億港元。公司公告稱,百奧泰生物製藥和百濟神州24日宣佈雙方已就百奧泰的BAT1706—一款在研安維汀®(貝伐珠單抗)生物類似藥籤訂了一項在中國的授權、分銷、供貨協議。根據協定條款,百奧泰已同意授權百濟神州在中國(包括港澳台地區)對BAT1706進行開發、生產及商業化,百奧泰將保留除上述地區以外的全球範圍內的相關權利。國家藥品監督管理局(NMPA)已於近日受理了百奧泰就BAT1706遞交的生物製劑許可證申請(BLA)。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.